{"transactions":[{"id":711191,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2026-07-10T20:14:56.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":false,"shares":3562,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.38,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":3562},"source":{"system":"sec-edgar","filing":"0001193125-26-300913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526300913/ownership.xml","form_type":"4"}},{"id":711190,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T20:14:56.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":true,"shares":3562,"price":2.38,"value":8477.56,"ownership":{"direct":true},"balance_after":6542,"source":{"system":"sec-edgar","filing":"0001193125-26-300913","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526300913/ownership.xml","form_type":"4"}},{"id":754747,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:00:03.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 81,000 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":81000,"derivative":{"exercise_price":5.95,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001193125-26-254122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000119312526254122/ownership.xml","form_type":"4"}},{"id":986970,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-26T15:13:05.000Z","date":"2025-11-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18668,"price":28.25,"value":527371.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of Class A Common Stock, par value $0.01 per share (\"Common Stock\") of Premier, Inc. (\"Issuer\") pursuant to the consummation of the transactions contemplated by the Agreement and Plan of Merger dated as of September 21, 2025 (the \"Merger Agreement\") by and among the Issuer, Premium Parent, LLC (\"Parent\") and Premium Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, at the effective time of the Merger on November 25, 2025 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted automatically into the right to receive $28.25 in cash, without interest (the \"Merger Consideration\"), subject to certain exceptions set forth in the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of the Issuer's Common Stock reported as disposed of by the reporting person include shares of Common Stock underlying outstanding time-based vesting restricted stock unit awards previously reported as beneficially owned by the reporting person (\"RSUs\") and granted to the reporting person prior to August 16, 2025. Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs was cancelled and converted into the right to receive an amount in cash, without interest, equal to the number of shares of Common Stock subject to the RSUs multiplied by the Merger Consideration (together with any accrued cash dividend equivalents)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of Class A Common Stock, par value $0.01 per share (\"Common Stock\") of Premier, Inc. (\"Issuer\") pursuant to the consummation of the transactions contemplated by the Agreement and Plan of Merger dated as of September 21, 2025 (the \"Merger Agreement\") by and among the Issuer, Premium Parent, LLC (\"Parent\") and Premium Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, at the effective time of the Merger on November 25, 2025 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted automatically into the right to receive $28.25 in cash, without interest (the \"Merger Consideration\"), subject to certain exceptions set forth in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of the Issuer's Common Stock reported as disposed of by the reporting person include shares of Common Stock underlying outstanding time-based vesting restricted stock unit awards previously reported as beneficially owned by the reporting person (\"RSUs\") and granted to the reporting person prior to August 16, 2025. Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs was cancelled and converted into the right to receive an amount in cash, without interest, equal to the number of shares of Common Stock subject to the RSUs multiplied by the Merger Consideration (together with any accrued cash dividend equivalents)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-298830","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000119312525298830/ownership.xml","form_type":"4"}},{"id":1086491,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-16T20:05:15.000Z","date":"2025-07-14","kind":"grant","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":33150,"derivative":{"exercise_price":0.82,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000950170-25-096242","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000095017025096242/ownership.xml","form_type":"4"}},{"id":1127639,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-02T21:43:56.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":22.88,"value":45760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2025."}],"balance_after":18668,"source":{"system":"sec-edgar","filing":"0000950170-25-080414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000095017025080414/ownership.xml","form_type":"4"}},{"id":1147446,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2025-05-15T21:10:09.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 13, 2026 or the date of the Company's 2026 Annual Meeting of Stockholders."}],"balance_after":28500,"derivative":{"exercise_price":0.3,"expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001739410-25-000087","document":"wk-form4_1747343402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000173941025000087/wk-form4_1747343402.xml","form_type":"4"}},{"id":1308024,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-07T19:38:22.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":21.42,"value":53550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is the weighted average price of all shares sold on the reported date in multiple transactions at prices ranging from $21.17 to $21.70. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20668,"source":{"system":"sec-edgar","filing":"0000950170-25-002730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000095017025002730/ownership.xml","form_type":"4"}},{"id":1337178,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-12-10T20:21:21.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":7101,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23168,"source":{"system":"sec-edgar","filing":"0000950170-24-134910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000095017024134910/ownership.xml","form_type":"4"}},{"id":1472028,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T22:04:05.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 27,700 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":27700,"derivative":{"exercise_price":4.37,"expiration_date":"2034-06-21","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0000950170-24-076384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000095017024076384/ownership.xml","form_type":"4"}},{"id":1488413,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:28:07.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 4, 2025 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":195000,"derivative":{"exercise_price":0.664,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001415889-24-015765","document":"form4-06062024_080604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000141588924015765/form4-06062024_080604.xml","form_type":"4"}},{"id":1488412,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:28:07.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":150647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 4, 2025 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":150647,"source":{"system":"sec-edgar","filing":"0001415889-24-015765","document":"form4-06062024_080604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000141588924015765/form4-06062024_080604.xml","form_type":"4"}},{"id":1511526,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2024-05-17T21:05:59.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 15, 2025 or the date of the Company's 2025 Annual Meeting of Stockholders."}],"balance_after":16500,"derivative":{"exercise_price":1.91,"expiration_date":"2034-05-15","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001739410-24-000093","document":"wk-form4_1715979949.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000173941024000093/wk-form4_1715979949.xml","form_type":"4"}},{"id":1514266,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-16T19:12:32.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":6629,"price":19.85,"value":131585.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is the weighted average price of all shares sold on the reported date in multiple transactions at prices ranging from $19.73 to $19.91. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":16067,"source":{"system":"sec-edgar","filing":"0000950170-24-061022","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000095017024061022/ownership.xml","form_type":"4"}},{"id":1721683,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-12-05T22:11:11.000Z","date":"2023-12-04","kind":"grant","planned":false,"acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22696,"source":{"system":"sec-edgar","filing":"0001209191-23-057475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000120919123057475/doc4.xml","form_type":"4"}},{"id":1814951,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-04T21:20:52.000Z","date":"2023-08-02","kind":"grant","planned":false,"acquired":true,"shares":155747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in twelve (12) equal quarterly installments beginning on August 2, 2023 such that the option will be fully vested and exercisable on August 2, 2026, subject to the Reporting Person's continued service to the Issuer on each such date."}],"balance_after":155747,"derivative":{"exercise_price":3.09,"expiration_date":"2033-08-02","underlying":"Common Stock","underlying_shares":155747},"source":{"system":"sec-edgar","filing":"0001209191-23-044635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000120919123044635/doc4.xml","form_type":"4"}},{"id":1873344,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-31T20:43:02.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":40258,"derivative":{"exercise_price":2.72,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0000950170-23-025380","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000095017023025380/ownership.xml","form_type":"4"}},{"id":1884734,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2023-05-19T21:25:11.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":15490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted under the Company's 2021 Equity Incentive Plan.  The option vests on the earlier of May 17, 2024 or the date of the Company's 2024 Annual Meeting of Stockholders."}],"balance_after":15490,"derivative":{"exercise_price":5.64,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":15490},"source":{"system":"sec-edgar","filing":"0000899243-23-013405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924323013405/doc4.xml","form_type":"4"}},{"id":2093266,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-07T22:08:51.000Z","date":"2022-12-05","kind":"grant","acquired":true,"shares":4636,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15363,"source":{"system":"sec-edgar","filing":"0001209191-22-060180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000120919122060180/doc4.xml","form_type":"4"}},{"id":2235957,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:31:10.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":40258,"derivative":{"exercise_price":4.32,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0000899243-22-021923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000089924322021923/doc4.xml","form_type":"4"}},{"id":2255331,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-05-27T00:09:50.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":13440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted under the Company's 2021 Equity Incentive Plan.  The option vests on the earlier of May 24, 2023 or the date of the Company's 2023 Annual Meeting of Stockholders."}],"balance_after":13440,"derivative":{"exercise_price":12.75,"expiration_date":"2032-05-24","underlying":"Common Stock","underlying_shares":13440},"source":{"system":"sec-edgar","filing":"0000899243-22-019830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924322019830/doc4.xml","form_type":"4"}},{"id":2482266,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-07T13:29:04.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":4098,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10727,"source":{"system":"sec-edgar","filing":"0001209191-21-068239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000120919121068239/doc4.xml","form_type":"4"}},{"id":2658822,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:07:24.000Z","date":"2021-06-19","kind":"grant","acquired":true,"shares":3434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 3,434 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":3434,"derivative":{"exercise_price":29.34,"expiration_date":"2031-06-19","underlying":"Common Stock","underlying_shares":3434},"source":{"system":"sec-edgar","filing":"0000899243-21-025416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000089924321025416/doc4.xml","form_type":"4"}},{"id":2931340,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-28T21:20:08.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":1286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 1,286 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the next annual meeting of the Issuer's shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":1286,"derivative":{"exercise_price":53.02,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":1286},"source":{"system":"sec-edgar","filing":"0000899243-20-035191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000089924320035191/doc4.xml","form_type":"4"}},{"id":2953462,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-08T21:44:44.000Z","date":"2020-12-07","kind":"grant","acquired":true,"shares":6629,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6629,"source":{"system":"sec-edgar","filing":"0001209191-20-062285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000120919120062285/doc4.xml","form_type":"4"}},{"id":4015505,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-05T22:31:19.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest and become exercisable in a series of installments, with the first installment to become exercisable for 25% of the\nunderlying common stock on February 1, 2019, and thereafter vesting and becoming exercisable in 12 quarterly installments as nearly equal as\npracticable (as determined by the Issuer in its reasonable discretion), until such stock option becomes fully exercisable on February 1, 2022,\nprovided that the Reporting Person remains an employee of Issuer at all times during the applicable vesting period of such securities."}],"balance_after":78000,"derivative":{"exercise_price":3.11,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001209191-18-016683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000120919118016683/doc4.xml","form_type":"4"}},{"id":4076405,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-02-05T22:20:48.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":13759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of PTI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full on February 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full on February 1, 2019."}],"balance_after":13759,"derivative":{"underlying":"Common Stock","underlying_shares":13759},"source":{"system":"sec-edgar","filing":"0001209191-18-007589","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000120919118007589/doc4.xml","form_type":"4"}},{"id":4243722,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":30995,"kind":"person","name":"Boudreau Helen M","position":1,"cik":"0001661481","reported_name":"Boudreau Helen M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-08-03T20:39:28.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest and become exercisable in a series of installments, with the first installment to become exercisable for 25% of the underlying common stock on July 25, 2018, and thereafter vesting and becoming exercisable in quarterly installments as nearly equal as practicable (as determined by the Issuer in its reasonable discretion), until such stock option becomes fully exercisable on July 25, 2021, provided that the Reporting Person remains an employee of Issuer at all times during the applicable vesting period of such securities."}],"balance_after":215000,"derivative":{"exercise_price":2.25,"expiration_date":"2027-07-25","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001209191-17-047371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661481/000120919117047371/doc4.xml","form_type":"4"}}]}